ArticleMethods in molecular biology (Clifton, N.J.)2025
In Vivo Model to Assess the Nasal Infection by Minor Group Rhinovirus.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rhinovirus primarily infects humans via nasal epithelial cells and is spread through the inhalation of shed progeny virus via micro-droplets containing the virus. A handful of studies have investigated the nasal mucosal responses to rhinovirus in experimentally infected healthy volunteers. There are also studies that have investigated the effect of antiviral drugs in reducing symptoms induced by rhinovirus infection. It is extremely expensive to test the antiviral drugs in human volunteers, and therefore having preclinical in vivo models is necessary to confirm the antiviral effect of the drugs prior to conducting clinical trials. The existing in vivo models for RV infection are focused on lung inflammation, which may be relevant to patients with chronic lung diseases, in whom rhinovirus causes lower respiratory tract infections. In this chapter, we describe a mouse model of rhinovirus infection, which shows self-limiting inflammation of the sinonasal mucosa.
Indexed as
Identifiers
40016463What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.